|
2012
|
Invention
|
Antithrombotic dual inhibitors comprising a biotin residue.
The present invention relates compou... |
|
2011
|
Invention
|
Bioassays for determining pd-1 modulation. The present invention relates to the identification an... |
|
|
Invention
|
(11beta, 17alpha)-11-(4-(2-11c-acetyl)phenyl)-17,23-epoxy-19,24-dinorchola-4,9,20-trien-3-one.
T... |
|
|
Invention
|
(11β,17α)-11-(4-(2-11c-acetyl)phenyl)-17,23-epoxy- 19,24-dinorchola-4,9,20-trien-3-one. The prese... |
|
|
Invention
|
Thieno (2, 3b) pyrazine compounds as b - raf inhibitors. The invention relates to compounds accor... |
|
|
Invention
|
16, 17-carbocyclic condensed steroid compounds having slective estrogenic activity.
The inventio... |
|
|
Invention
|
8-methyl-1-phenyl-imidazol[1,5-a]pyrazine compounds. The present invention provides 8-methyl-1 -p... |
|
|
Invention
|
1h-[1,2,3]triazolo[4,5-c]pyridine-4-carbonitrile derivatives. The invention relates to 1H-[1,2,3]... |
|
2010
|
Invention
|
Amino-heteroaryl derivatives as hcn blockers. The invention relates to amino-heteroaryl derivativ... |
|
|
Invention
|
Mk2 inhibitors. The present invention relates to compounds of general Formula (I) or a pharmaceut... |
|
|
Invention
|
Heterocylic compounds as antagonists of the orexin receptors. The present invention relates to a ... |
|
|
Invention
|
Heterocyclic derivatives. The present invention relates to a heterocyclic derivative of formula (... |
|
|
Invention
|
(1,1, 1,3, 3, 3-hexafluoro-2-hydroxypropan-2-yl) phenyl derivatives, pharmaceutical compositions ... |
|
|
Invention
|
Condensed azine - derivatives for the treatment of diseases related to the acetylcholine receptor... |
|
|
Invention
|
S-mirtazapine for the treatment of hot flush.
The invention provides a method of treatment of ho... |
|
2009
|
Invention
|
2-(benzimidazol-1-yl)-n-(4-phenylthiazol-2-yl) acetamide derivatives.
The invention relates 2-(b... |
|
|
Invention
|
Use of chemical chelators as reversal agents for drug-induced neuromuscular block.
The invention... |
|
|
Invention
|
Purification of protein hydrolysate and the result and products.
The present invention relates t... |
|
|
Invention
|
Preparation of a pharmaceutical composition for increasing bone mineral density.
The present inv... |
|
|
Invention
|
Treatment of bipolar disorders and associated symptoms.
The present invention relates to a metho... |
|
2008
|
Invention
|
Method of hormone suppression in humans.
The present invention relates to a glycine transporter-... |
|
2007
|
Invention
|
V3 antagonists for the treatment or prevention of chronic pain.
The present invention relates to... |
|
|
Invention
|
Ih channel inhibitors for the promotion of wakefulness.
The present invention relates to use of ... |
|
|
Invention
|
Mirtazapine for the treatment of neuropathic pain.
This invention relates to a method of treatme... |
|
|
Invention
|
Method of weaning from hormonal treatment of hormone depletion induced vasomotor symptoms.
The i... |
|
|
Invention
|
Selective enzymatic hydrolysis of c-terminal tert-butyl esters of peptides.
The present inventio... |
|
2006
|
Invention
|
2-(benzimidazol-1-yl)-n-(4-phenylthiazol-2-yl) acetamide derivatives.
The invention relates 2-(... |
|
|
Invention
|
Antithrombotic compound.
The present invention relates compounds of the formula I: oligosacchari... |
|
|
Invention
|
Synergistic combination for the treatment of pain (cannabinoid receptor agonist and opioid recept... |
|
|
Invention
|
1-benzylindole-2-carboxamide derivatives. The present invention relates to i-benzylindole-2-carbo... |
|
|
Invention
|
Glycine reuptake inhibitors for treatment of drug dependence.
The invention relates to a method ... |
|
2005
|
Invention
|
Drug combination comprising a selective serotonin reuptake inhibitor and a glucocorticoid recepto... |
|
|
Invention
|
Treatment of bipolar disorders and associated symptoms.
The present invention relates to a meth... |
|
|
Invention
|
Pulmonary administration of an antithrombotic compound.
The invention relates to the use of an o... |
|
|
Invention
|
Process for the preparation 2-substituted-derivatives of estrone and estradiol. The invention pro... |
|
2004
|
Invention
|
Method for protein isolation in anoxic conditions.
The present invention relates to a method for... |
|
1994
|
Invention
|
Progestogen-only contraceptive. Disclosed is an oral contraceptive regimen containing daily dosag... |
|
1992
|
Invention
|
Pharmaceutical granulate. Disclosed is a process of preparing granules involving first preparing ... |
|
1985
|
P/S
|
Pharmaceutical preparations and medicines for human use. |
